UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2017
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-34785
FORM Holdings Corp.
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 20-4988129 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| 780 Third Avenue, 12th Floor, New York, NY | 10017 | |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s Telephone Number, Including Area Code): (212) 309-7549
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ¨ | Accelerated filer ¨ |
| Non-accelerated filer ¨ (Do not check if a smaller reporting company) | Smaller reporting company x |
| Emerging growth company ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
As of November 9, 2017, 26,545,690 shares of the registrant’s common stock were outstanding.
FORM Holdings Corp.
Table of Contents
Part I - FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
FORM Holdings Corp. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
| September 30, 2017 (Unaudited) | December 31, 2016 | |||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 10,072 | $ | 17,910 | ||||
| Accounts receivable, net | 2,668 | 404 | ||||||
| Inventory | 4,044 | 2,890 | ||||||
| Other current assets | 630 | 2,150 | ||||||
| Assets held for disposal | 451 | 1,507 | ||||||
| Total current assets | 17,865 | 24,861 | ||||||
| Restricted cash | 487 | 638 | ||||||
| Property and equipment, net | 14,411 | 16,284 | ||||||
| Intangible assets, net | 13,897 | 15,233 | ||||||
| Goodwill | 25,836 | 24,409 | ||||||
| Other assets | 1,343 | 1,382 | ||||||
| Total assets | $ | 73,839 | $ | 82,807 | ||||
| Current liabilities | ||||||||
| Accounts payable, accrued expenses and other current liabilities | $ | 10,401 | $ | 11,434 | ||||
| Deferred revenue | 174 | 133 | ||||||
| Liabilities held for disposal | 80 | 206 | ||||||
| Total current liabilities | 10,655 | 11,773 | ||||||
| Long-term liabilities | ||||||||
| Debt | 6,500 | 6,500 | ||||||
| Derivative warrant liabilities | 52 | 259 | ||||||
| Other liabilities | 796 | 106 | ||||||
| Total liabilities | 18,003 | 18,638 | ||||||
| Commitments and contingencies (see Note 11) | ||||||||
| Equity | ||||||||
| Series A Convertible Preferred stock, $0.01 par value per share; 500,000 shares authorized; 6,968 issued and none outstanding | — | — | ||||||
| Series B Convertible Preferred stock, $0.01 par value per share; 5,000,000 shares authorized; 1,666,667 issued and none outstanding | — | — | ||||||
| Series C Junior Preferred stock, $0.01 par value per share; 300,000 shares authorized; none issued and outstanding | — | — | ||||||
| Series D Convertible Preferred Stock, $0.01 par value per share; 500,000 shares authorized; 475,208 issued and 420,541 outstanding with a liquidation value of $20,186 as of September 30, 2017; 491,427 issued and outstanding with a liquidation value of $23,588 as of December 31, 2016 | 4 | 5 | ||||||
| Common stock, $0.01 par value per share; 150,000,000 shares authorized; 26,540,690 and 18,304,881 issued and outstanding as of September 30, 2017 and December 31, 2016, respectively | 265 | 183 | ||||||
| Additional paid-in capital | 289,823 | 280,221 | ||||||
| Accumulated deficit | (239,000 | ) | (220,868 | ) | ||||
| Accumulated other comprehensive loss | (133 | ) | (13 | ) | ||||
| Total equity attributable to the Company | 50,959 | 59,528 | ||||||
| Noncontrolling interests | 4,877 | 4,641 | ||||||
| Total equity | 55,836 | 64,169 | ||||||
| Total liabilities and equity | $ | 73,839 | $ | 82,807 | ||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
3
FORM Holdings Corp. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(In thousands, except share and per share data)
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Revenue | ||||||||||||||||
| Wellness | $ | 12,652 | $ | — | $ | 36,563 | $ | — | ||||||||
| Technology | 4,879 | 1,751 | 11,820 | 5,478 | ||||||||||||
| Intellectual property | 200 | 1,350 | 300 | 11,000 | ||||||||||||
| Total revenue | 17,731 | 3,101 | 48,683 | 16,478 | ||||||||||||
| Cost of sales | ||||||||||||||||
| Wellness | 10,347 | — | 29,583 | — | ||||||||||||
| Technology | 3,902 | 1,554 | 9,520 | 4,858 | ||||||||||||
| Intellectual property* | 126 | 1,164 | 343 | 6,127 | ||||||||||||
| Total cost of sales | 14,375 | 2,718 | 39,446 | 10,985 | ||||||||||||
| Depreciation, amortization and impairment | 1,894 | 182 | 6,849 | 13,341 | ||||||||||||
| General and administrative* | 5,473 | 3,564 | 17,012 | 8,059 | ||||||||||||
| Total operating expenses | 21,742 | 6,464 | 63,307 | 32,385 | ||||||||||||
| Operating loss from continuing operations | (4,011 | ) | (3,363 | ) | (14,624 | ) | (15,907 | ) | ||||||||
| Non-operating income (expense), net | (85 | ) | (272 | ) | (24 | ) | 246 | |||||||||
| Interest expense | (183 | ) | (949 | ) | (550 | ) | (1,697 | ) | ||||||||
| Extinguishment of debt | — | (262 | ) | — | (472 | ) | ||||||||||
| Loss from continuing operations before income taxes | (4,279 | ) | (4,846 | ) | (15,198 | ) | (17,830 | ) | ||||||||
| Income tax expense | (57 | ) | — | (284 | ) | — | ||||||||||
| Consolidated net loss from continuing operations | (4,336 | ) | (4,846 | ) | (15,482 | ) | (17,830 | ) | ||||||||
| Loss from discontinued operations before income taxes | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Income tax expense | — | — | — | — | ||||||||||||
| Net loss from discontinued operations | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Consolidated net loss | (4,544 | ) | (5,261 | ) | (17,803 | ) | (20,023 | ) | ||||||||
| Net income attributable to noncontrolling interests | (153 | ) | — | (329 | ) | — | ||||||||||
| Net loss attributable to the Company | $ | (4,697 | ) | $ | (5,261 | ) | $ | (18,132 | ) | $ | (20,023 | ) | ||||
| Consolidated net loss from continuing operations | $ | (4,336 | ) | $ | (4,846 | ) | $ | (15,482 | ) | $ | (17,830 | ) | ||||
| Other comprehensive income (loss) from continuing operations: foreign currency translations | 31 | — | (120 | ) | — | |||||||||||
| Comprehensive loss from continuing operations | (4,305 | ) | (4,846 | ) | (15,602 | ) | (17,830 | ) | ||||||||
| Consolidated net loss from discontinued operations | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Other comprehensive loss from discontinued operations: foreign currency translations | — | — | — | — | ||||||||||||
| Comprehensive loss from discontinued operations | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Comprehensive loss | $ | (4,513 | ) | $ | (5,261 | ) | $ | (17,923 | ) | $ | (20,023 | ) | ||||
| Loss per share: | ||||||||||||||||
| Basic and diluted net loss per share | ||||||||||||||||
| Loss per share from continuing operations | $ | (0.19 | ) | $ | (0.31 | ) | $ | (0.76 | ) | $ | (1.20 | ) | ||||
| Loss per share from discontinued operations | (0.01 | ) | (0.03 | ) | (0.11 | ) | (0.15 | ) | ||||||||
| Total basic and diluted net loss per share | $ | (0.20 | ) | $ | (0.34 | ) | $ | (0.87 | ) | $ | (1.35 | ) | ||||
| Weighted-average number of shares outstanding during the period: | ||||||||||||||||
| Basic | 24,144,002 | 15,473,895 | 20,852,034 | 14,880,925 | ||||||||||||
| Diluted | 24,144,002 | 15,473,895 | 20,852,034 | 14,880,925 | ||||||||||||
| *Includes stock-based compensation expense, as follows: | ||||||||||||||||
| Intellectual property | $ | — | $ | 59 | $ | — | $ | 191 | ||||||||
| General and administrative | 706 | 426 | 2,179 | 1,256 | ||||||||||||
| Total stock-based compensation expense | $ | 706 | $ | 485 | $ | 2,179 | $ | 1,447 | ||||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
4
FORM Holdings Corp. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)
(In thousands)
| Preferred stock |
Common stock |
Additional paid-in capital |
Accumulated deficit |
Accumulated other comprehensive loss |
Total FORM equity |
Non controlling interests |
Total equity |
|||||||||||||||||||||||||
| December 31, 2016 | $ | 5 | $ | 183 | $ | 280,221 | $ | (220,868 | ) | $ | (13 | ) | $ | 59,528 | $ | 4,641 | $ | 64,169 | ||||||||||||||
| Issuance of common stock for services | — | — | 20 | — | — | 20 | — | 20 | ||||||||||||||||||||||||
| Shares of common stock issued for the acquisition of Excalibur | — | 9 | 1,800 | — | — | 1,809 | — | 1,809 | ||||||||||||||||||||||||
| Net proceeds from sale and issuance of shares of common stock in public offering | — | 69 | 6,515 | — | — | 6,584 | — | 6,584 | ||||||||||||||||||||||||
| Decrease in shares of preferred stock issued to XpresSpa sellers | — | — | (908 | ) | — | — | (908 | ) | — | (908 | ) | |||||||||||||||||||||
| Conversion of preferred stock to common stock | (1 | ) | 4 | (4 | ) | — | — | (1 | ) | — | (1 | ) | ||||||||||||||||||||
| Stock-based compensation | — | — | 2,179 | — | — | 2,179 | — | 2,179 | ||||||||||||||||||||||||
| Net loss for the period | — | — | — | (18,132 | ) | — | (18,132 | ) | 329 | (17,803 | ) | |||||||||||||||||||||
| Foreign currency translation | — | — | — | — | (120 | ) | (120 | ) | — | (120 | ) | |||||||||||||||||||||
| Net distributions to noncontrolling interests |
— | — | — | — | — | — | (93 | ) | (93 | ) | ||||||||||||||||||||||
| September 30, 2017 | $ | 4 | $ | 265 | $ | 289,823 | $ | (239,000 | ) | $ | (133 | ) | $ | 50,959 | $ | 4,877 | $ | 55,836 | ||||||||||||||
| Preferred stock |
Common stock |
Additional paid-in capital |
Accumulated deficit |
Accumulated other comprehensive loss |
Total FORM equity |
Non controlling interests |
Total equity |
|||||||||||||||||||||||||
| December 31, 2015 | $ | — | $ | 132 | $ | 237,246 | $ | (196,862 | ) | $ | — | $ | 40,516 | $ | — | $ | 40,516 | |||||||||||||||
| Vesting of restricted stock units (“RSUs”) | — | 1 | (1 | ) | — | — | — | — | — | |||||||||||||||||||||||
| Issuance of common stock for repayment of convertible debt and related interest | — | 18 | 3,031 | — | — | 3,049 | — | 3,049 | ||||||||||||||||||||||||
| Sale of shares of common stock from subscription agreement | — | 7 | 1,727 | — | — | 1,734 | — | 1,734 | ||||||||||||||||||||||||
| Stock-based compensation | — | — | 1,447 | — | — | 1,447 | — | 1,447 | ||||||||||||||||||||||||
| Net loss for the period | — | — | — | (20,023 | ) | — | (20,023 | ) | — | (20,023 | ) | |||||||||||||||||||||
| September 30, 2016 | $ | — | $ | 158 | $ | 243,450 | $ | (216,885 | ) | $ | — | $ | 26,723 | $ | — | $ | 26,723 | |||||||||||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
5
FORM Holdings Corp. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
| Nine months ended September 30, | ||||||||
| 2017 | 2016 | |||||||
| Cash flows from operating activities | ||||||||
| Consolidated net loss | $ | (17,803 | ) | $ | (20,023 | ) | ||
| Adjustments to reconcile consolidated net loss to net cash used in operating activities: | ||||||||
| Items not affecting cash flows | ||||||||
| Depreciation and amortization | 6,849 | 1,404 | ||||||
| Impairment of intangible assets | — | 11,937 | ||||||
| Amortization of debt discount and debt issuance costs | — | 1,798 | ||||||
| Stock-based compensation | 2,179 | 1,447 | ||||||
| Amendment to warrants as part of debt modification | — | (281 | ) | |||||
| Extinguishment of debt | — | 356 | ||||||
| Issuance of shares of common stock for services | 20 | 53 | ||||||
| Gain on disposal of asset | (148 | ) | — | |||||
| Change in fair value of derivative warrant liabilities and conversion feature | (207 | ) | 185 | |||||
| Conversion of shares of preferred stock to shares of common stock | (1 | ) | — | |||||
| Exchange rate gain, net | — | (76 | ) | |||||
| Changes in current assets and liabilities net of effects of acquisition | ||||||||
| Increase in accounts receivable, net | (1,729 | ) | (1,581 | ) | ||||
| Increase in inventory | (1,103 | ) | (89 | ) | ||||
| Decrease in other current assets and other assets | 1,739 | 307 | ||||||
| Increase (decrease) in accounts payable, accrued expenses and other current liabilities | (1,593 | ) | 1,502 | |||||
| Increase (decrease) in deferred revenue | (79 | ) | 81 | |||||
| Decrease in other liabilities | (13 | ) | (267 | ) | ||||
| Net cash used in operating activities – continuing operations | (11,889 | ) | (3,247 | ) | ||||
| Net cash provided by operating activities – discontinued operations | 930 | 278 | ||||||
| Net cash used in operating activities | (10,959 | ) | (2,969 | ) | ||||
| Cash flows from investing activities | ||||||||
| Cash acquired as part of acquisition | 26 | — | ||||||
| Acquisition of property and equipment | (2,734 | ) | (243 | ) | ||||
| Acquisition of software | (331 | ) | — | |||||
| Proceeds from sale of asset | 150 | — | ||||||
| Decrease in deposits | — | 2,001 | ||||||
| Increase in investments | — | (1,734 | ) | |||||
| Net cash provided by (used in) investing activities | (2,889 | ) | 24 | |||||
| Cash flows from financing activities | ||||||||
| Proceeds from commitments to issue common stock under subscription agreement | — | 1,734 | ||||||
| Net proceeds from sale and issuance of shares of common stock in public offering | 6,584 | — | ||||||
| Repayment of debt and line of credit | (361 | ) | (2,011 | ) | ||||
| Net distributions to noncontrolling interests | (93 | ) | — | |||||
| Debt issuance costs | — | (50 | ) | |||||
| Net cash provided by (used in) financing activities | 6,130 | (327 | ) | |||||
| Effect of exchange rate changes on cash and cash equivalents | (120 | ) | — | |||||
| Decrease in cash and cash equivalents | (7,838 | ) | (3,272 | ) | ||||
| Cash and cash equivalents at beginning of period | 17,910 | 24,951 | ||||||
| Cash and cash equivalents at end of period | $ | 10,072 | $ | 21,679 | ||||
| Cash paid during the period for | ||||||||
| Interest | $ | 580 | $ | 40 | ||||
| Noncash investing and financing transactions | ||||||||
| Issuance of common stock to repay debt and interest | — | 2,996 | ||||||
The accompanying notes form an integral part of these condensed consolidated financial statements.
6
FORM Holdings Corp. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(In thousands, except for share and per share data)
Note 1. General
FORM Holdings Corp. (“FORM” or the “Company”) has three operating segments: wellness, technology and intellectual property.
The Company’s wellness operating segment consists of XpresSpa, which is a leading airport retailer of spa services. XpresSpa is a well-recognized airport spa brand with 51 locations, consisting of 47 domestic and 4 international, as of September 30, 2017. XpresSpa offers travelers premium spa services, including massage, nail and hair as well as spa and travel products. The Company acquired XpresSpa in the fourth quarter of 2016.
The Company’s technology operating segment consists of Group Mobile as well as an 11% equity interest in InfoMedia Services Limited (“InfoMedia”). Group Mobile offers rugged hardware and software solutions, including laptops, tablets, and mobile printers, as well as installation and deployment services. The Company acquired Group Mobile in the fourth quarter of 2015 and Excalibur Integrated Systems Inc. (“Excalibur”), which was merged with Group Mobile, in the first quarter of 2017. The Company’s equity interest in InfoMedia increased from 8.25% to 11% in the first quarter of 2017 due to a realignment of ownership interests.
The Company is currently evaluating strategic alternatives with respect to Group Mobile in an attempt to enhance stockholder value. These strategic alternatives may include a possible sale, merger, spin-off or other separation of Group Mobile or other forms of business combinations or strategic transactions. The Company is seeking to enter into one or more strategic transactions involving Group Mobile in the first quarter of 2018.
The Company’s intellectual property operating segment is engaged in the monetization of patents related to content and ad delivery, remote monitoring and mobile technologies.
As further detailed in Note 10 “Discontinued Operations and Assets and Liabilities Held for Disposal,” in June 2017, the Company concluded that the requirement to report the results of FLI Charge as discontinued operations was triggered. FLI Charge was subsequently sold in October 2017.
On July 26, 2017, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC, acting as the representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 6,900,000 shares of the Company’s common stock, par value $0.01 per share (“FORM Common Stock”) including 900,000 shares subject to the Underwriters’ over-allotment option, which was exercised on August 2, 2017 and closed on August 4, 2017. The price to the public in the Offering was $1.10 per share and the Underwriters agreed to purchase the shares of FORM Common Stock from the Company pursuant to the Underwriting Agreement at a purchase price of $1.023 per share. The net proceeds to the Company from the Offering were $6,584 after deducting underwriting discounts and commissions and other estimated offering expenses.
Note 2. Accounting and Reporting Policies
(a) Basis of presentation and principles of consolidation
The accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2016. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three and nine-month periods ended September 30, 2017 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.
(b) Use of estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s intangible assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies.
(c) Revenue recognition
The Company recognizes revenue for the wellness operating segment from the sale of XpresSpa products and services at the point of sale, net of discounts and applicable sales taxes. Revenues from the XpresSpa wholesale and e-commerce businesses are recorded at the time goods are shipped. The Company excludes all sales taxes assessed to its customers. Sales taxes assessed on revenues are included in accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheets until remitted to the state agencies.
The Company records revenue from product sales in the technology operating segment when title and risk of loss are passed to the customer, there is persuasive evidence of an arrangement for sale, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. The Company’s shipping terms typically specify F.O.B. destination, at which time title and risk of loss have passed to the customer. At the time of sale of hardware products, the Company records an estimate for sales returns and allowances based on historical experience. Hardware products sold by the Company are warranted by the vendor.
7
The Company has drop-shipment arrangements with many of its hardware vendors and suppliers to deliver products directly to customers. Revenue for drop-shipment arrangements is recorded on a gross basis upon delivery to the customer with contract terms that typically specify F.O.B. destination. Revenue is recognized on a gross basis, as the Company is the principal in the transaction, as the primary obligor in the arrangement, assumes the inventory risk if the product is returned by the customer, sets the price of the product to the customer, assumes credit risk for the amounts invoiced, and works closely with the customers to determine their hardware specifications.
Freight billed to customers is recognized as net product revenue and the related freight costs as a cost of sales.
On certain occasions, the Company’s technology operating segment will enter into a bill and hold arrangement with a customer. When this occurs, the Company makes a determination as to when it will be the proper time to recognize revenue. In doing so, the Company takes the following into consideration:
| • | whether the risks of ownership have passed to the customer; |
| • | the customer must have made a fixed commitment to purchase the goods; |
| • | the customer must request and have a substantial business purpose for ordering on a bill and hold basis; |
| • | there must be a fixed schedule for delivery that is reasonable and consistent with the customer’s business purpose; |
| • | the Company cannot retain any specific performance obligations that would make the earnings process incomplete; |
| • | the goods must be segregated from remaining inventory (i.e., they cannot be used to fill orders for others); and |
| • | the goods must be complete and ready for shipment. |
For multiple-element arrangements in the Company’s technology operating segment that include hardware products, services and maintenance, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”) and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company allocates revenue to all deliverables based on the VSOE of each element, and if VSOE does not exist revenue is recognized when elements lacking VSOE are delivered.
Revenue from patent licensing is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. Currently, revenue arrangements related to intellectual property provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met.
8
(d) Cost of sales
Cost of sales for the Company’s wellness operating segment consists of store-level costs. Store-level costs include all costs that are directly attributable to the store operations and include:
| • | payroll and related benefits for store operations and store-level management; |
| • | rent, percentage rent and occupancy costs; |
| • | the cost of merchandise; |
| • | freight, shipping and handling costs; |
| • | production costs; |
| • | inventory shortage and valuation adjustments, including purchase price allocation increase in fair values which was recorded as part of acquisition; and |
| • | costs associated with sourcing operations. |
Cost of sales for the Company’s technology operating segment includes costs to acquire or manufacture goods for inventory.
Cost of sales for the Company’s intellectual property operating segment mainly includes expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as related internal payroll expenses.
(e) Recently adopted accounting pronouncements
ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business
In January 2017, the FASB issued Accounting Standards Update No. 2017-01 (“ASU 2017-01”) “Business Combinations (Topic 805): Clarifying the Definition of a Business.” ASU 2017-01 provides guidance to evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. If substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single asset or a group of similar assets, the assets acquired (or disposed of) are not considered a business. The Company adopted ASU 2017-01 as of January 1, 2017 on a prospective basis.
(f) Recently issued accounting pronouncements not yet adopted
ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606)
The core principle of the new standard is that revenue should be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance was amended in July 2015 and is effective for annual reporting periods beginning after December 15, 2017. As such, the Company is currently assessing the impact of the adoption on its condensed consolidated financial statements. The Company will adopt the new standard and related updates effective January 1, 2018, and intends to use the modified retrospective method of adoption.
Based upon its preliminary assessment undertaken through September 30, 2017, the Company expects that the new standard will have an impact on revenue recognition for Group Mobile contracts in its technology operating segment, and expects to conclude on this assessment by December 31, 2017. The Company does not expect for there to be an impact on revenue recognition for its wellness operating segment, as the revenue is recognized when the service is performed and payment is collected from the customer.
The Company continues to monitor additional changes, modifications, clarifications or interpretations being undertaken by the FASB, which may, in conjunction with the completion of the Company’s overall assessment of the new guidance, impact the Company’s current conclusions.
ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment
In January 2017, the FASB issued Accounting Standards Update No. 2017-04 (“ASU 2017-04”) “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019; early adoption is permitted. The Company currently anticipates that the adoption of ASU 2017-04 will not have a material impact on its consolidated financial statements.
ASU No. 2017-09, Stock Compensation (Topic 718): Scope of Modification Accounting
In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (“ASU 2017-09”) “Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The current disclosure requirements in Topic 718 apply regardless of whether an entity is required to apply modification accounting under the amendments in this update. ASU 2017-09 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017; early adoption is permitted. The Company is currently in the process of evaluating the potential impact of the adoption on its consolidated financial statements.
(g) Reclassification
Certain balances have been reclassified to conform to presentation requirements, including presentation of discontinued operations and assets and liabilities held for disposal with respect to the Company’s FLI Charge business (refer to Note 10), as well as consistent presentation of cost of sales and general and administrative expenses to align presentation for operating segments.
Note 3. Net Loss per Share of Common Stock
Basic net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. However, as the Company generated a net loss in all periods presented, potentially dilutive securities, including certain warrants and stock options, were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive.
9
The table below presents the computation of basic and diluted net loss per share of common stock:
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Basic numerator: | ||||||||||||||||
| Net loss from continuing operations attributable to shares of common stock | $ | (4,489 | ) | $ | (4,846 | ) | $ | (15,811 | ) | $ | (17,830 | ) | ||||
| Net loss from discontinued operations attributable to shares of common stock | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Net loss attributable to shares of common stock | $ | (4,697 | ) | $ | (5,261 | ) | $ | (18,132 | ) | $ | (20,023 | ) | ||||
| Basic denominator: | ||||||||||||||||
| Basic shares of common stock outstanding | 24,144,002 | 15,473,895 | 20,852,034 | 14,880,925 | ||||||||||||
| Basic loss per share of common stock from continuing operations | $ | (0.19 | ) | $ | (0.31 | ) | $ | (0.76 | ) | $ | (1.20 | ) | ||||
| Basic loss per share of common stock from discontinued operations | (0.01 | ) | (0.03 | ) | (0.11 | ) | (0.15 | ) | ||||||||
| Basic net loss per share of common stock | $ | (0.20 | ) | $ | (0.34 | ) | $ | (0.87 | ) | $ | (1.35 | ) | ||||
| Diluted numerator: | ||||||||||||||||
| Net loss from continuing operations attributable to shares of common stock | $ | (4,489 | ) | $ | (4,846 | ) | $ | (15,811 | ) | $ | (17,830 | ) | ||||
| Net loss from discontinued operations attributable to shares of common stock | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Net loss attributable to shares of common stock | $ | (4,697 | ) | $ | (5,261 | ) | $ | (18,132 | ) | $ | (20,023 | ) | ||||
| Diluted denominator: | ||||||||||||||||
| Diluted shares of common stock outstanding | 24,144,002 | 15,473,895 | 20,852,034 | 14,880,925 | ||||||||||||
| Diluted loss per share of common stock from continuing operations | $ | (0.19 | ) | $ | (0.31 | ) | $ | (0.76 | ) | $ | (1.20 | ) | ||||
| Diluted loss per share of common stock from discontinued operations | (0.01 | ) | (0.03 | ) | (0.11 | ) | (0.15 | ) | ||||||||
| Diluted net loss per share of common stock | $ | (0.20 | ) | $ | (0.34 | ) | $ | (0.87 | ) | $ | (1.35 | ) | ||||
| Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact: | ||||||||||||||||
| Both vested and unvested options to purchase an equal number of shares of common stock of the Company | 4,876,899 | 1,492,434 | 4,876,899 | 1,492,434 | ||||||||||||
| Unvested RSUs to issue an equal number of shares of common stock of the Company | 365,565 | — | 365,565 | — | ||||||||||||
| Warrants to purchase an equal number of shares of common stock of the Company | 3,087,500 | 1,006,679 | 3,087,500 | 1,006,679 | ||||||||||||
| Preferred stock on an as converted basis | 3,439,587 | — | 3,620,626 | — | ||||||||||||
| Conversion feature of senior secured notes | — | — | — | 105,920 | ||||||||||||
| Total number of potentially dilutive instruments, excluded from the calculation of net loss per share | 11,769,551 | 2,499,113 | 11,950,590 | 2,605,033 | ||||||||||||
Note 4. Business Combinations
XpresSpa
During the second quarter of 2017, the Company learned new information about legal and other professional costs which existed as of the acquisition date of XpresSpa. As a result, the Company and the sellers of XpresSpa (the “XpresSpa Sellers”) agreed to reduce the total amount of Series D Convertible Preferred Stock (“FORM Preferred Stock”), which was previously issued to the XpresSpa Sellers in conjunction with the acquisition of XpresSpa. The Company reduced the number of the FORM Preferred Stock by 16,219 shares and estimated that the fair value of the reduction of the consideration was $908, which was recorded as a reduction of preferred equity and goodwill.
Additionally, during the second and third quarters of 2017, certain XpresSpa Sellers converted an aggregate of 54,667 shares of their FORM Preferred Stock into 437,235 shares of the Company’s common stock, par value $0.01 per share.
As a result of these events, the total number of shares of FORM Preferred Stock was reduced from 491,427 as of December 31, 2016 to 420,541 shares as of September 30, 2017 and the face value (and liquidation preference) was reduced from $23,588 to $20,186.
Group Mobile
On February 2, 2017, the Company acquired Excalibur, which is an end-to-end solutions provider of mobile hardware devices, wireless network security, data networking, telephony and mobile application development and software solutions. Following the acquisition, Excalibur was merged with Group Mobile within the Company’s technology operating segment.
10
In consideration for the acquisition, the Company issued 888,573 unregistered shares of the Company’s common stock, par value $0.01 per share, to the former stockholders of Excalibur (the “Excalibur Sellers”). In addition, the Excalibur Sellers will, in the three years following the closing of this transaction, also receive $500 for each $2,000 of gross profit generated by a specified list of Excalibur accounts annually, until such cumulative gross profit reaches $6,000, and an additional $500 when such cumulative profit reaches $10,000, such amounts are payable in either cash or the Company’s common stock, at the election of the Company.
The fair value of the total purchase price is $2,125 and includes a fair value of contingent consideration of $316 and fair value of unregistered shares of common stock issued of $1,809.
Assets acquired and liabilities assumed were recorded at their fair values as of the acquisition date. The purchase price for the acquisition was allocated to the net tangible and intangible assets based on their fair values as of the acquisition date. The excess of the purchase price over the net tangible assets and intangible assets was recorded as goodwill. The table below presents preliminary allocation of the purchase price:
| Fair Value | ||||
| Assets | ||||
| Current assets (including cash of $26) | $ | 613 | ||
| Deferred tax assets | 29 | |||
| Property and equipment | 21 | |||
| Intangible assets | 556 | |||
| Goodwill | 2,335 | |||
| Total assets | 3,554 | |||
| Liabilities | ||||
| Accounts payable and accrued expenses | 1,214 | |||
| Deferred tax liabilities | 215 | |||
| Total liabilities | 1,429 | |||
| Net assets, fair value | $ | 2,125 | ||
The allocation of the purchase price was based upon a preliminary valuation performed using the Company's estimates and assumptions, which are subject to change within the measurement period (up to one year from the acquisition date).
Note 5. Segment Information
The Company’s operating segments are defined as components of an enterprise about which separate financial information is available that is regularly evaluated by the enterprise’s chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company concluded that it conducts its business through three operating segments, which are also its reportable segments:
| • | wellness (XpresSpa); |
| • | technology (Group Mobile); and |
| • | intellectual property |
Segment operating results reflect losses before corporate and unallocated shared expenses, interest expense and income taxes. Corporate and unallocated shared expenses principally consist of costs for corporate functions, rent for office space, stock-based compensation, executive management and certain unallocated administrative support functions.
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Revenue | ||||||||||||||||
| Wellness | $ | 12,652 | $ | — | $ | 36,563 | $ | — | ||||||||
| Technology | 4,879 | 1,751 | 11,820 | 5,478 | ||||||||||||
| Intellectual property | 200 | 1,350 | 300 | 11,000 | ||||||||||||
| Total revenue | 17,731 | 3,101 | 48,683 | 16,478 | ||||||||||||
| Cost of sales | ||||||||||||||||
| Wellness | 10,347 | — | 29,583 | — | ||||||||||||
| Technology | 3,902 | 1,554 | 9,520 | 4,858 | ||||||||||||
| Intellectual property | 126 | 1,164 | 343 | 6,127 | ||||||||||||
| Total cost of sales | 14,375 | 2,718 | 39,446 | 10,985 | ||||||||||||
| Segment operating income (loss) | ||||||||||||||||
| Wellness | (1,639 | ) | — | (6,002 | ) | — | ||||||||||
| Technology | (490 | ) | (565 | ) | (2,146 | ) | (1,213 | ) | ||||||||
| Intellectual property | 217 | 113 | 86 | (8,167 | ) | |||||||||||
| Corporate | (2,099 | ) | (2,911 | ) | (6,562 | ) | (6,527 | ) | ||||||||
| Total segment operating loss | (4,011 | ) | (3,363 | ) | (14,624 | ) | (15,907 | ) | ||||||||
| Corporate non-operating expense, net | (268 | ) | (1,483 | ) | (574 | ) | (1,923 | ) | ||||||||
| Loss from continuing operations before income taxes | $ | (4,279 | ) | $ | (4,846 | ) | $ | (15,198 | ) | $ | (17,830 | ) | ||||
11
| September 30, 2017 |
December 31, 2016 |
|||||||
| Assets | ||||||||
| Wellness | $ | 51,151 | $ | 57,527 | ||||
| Technology | 14,445 | 7,014 | ||||||
| Intellectual property | 603 | 940 | ||||||
| Corporate | 7,189 | 15,819 | ||||||
| Assets held for disposal | 451 | 1,507 | ||||||
| Total assets | $ | 73,839 | $ | 82,807 | ||||
General and administrative costs are allocated among the operating segments and non-operating corporate segment. The non-operating corporate segment does not have any revenue, but does incur expenses such as compensation expenses, rent and infrastructure costs. The non-operating corporate segment’s assets are mainly comprised of cash.
The Company currently operates in two geographical regions: United States and all other countries. The following table represents the geographical revenue, regional operating loss, and total asset information as of and for the three and nine months ended September 30, 2017 and 2016. There were no concentrations of geographical revenue, regional operating loss or total assets related to any single foreign country that were material to the Company’s condensed consolidated financial statements.
| Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Revenue | ||||||||||||||||
| United States | $ | 16,228 | $ | 3,101 | $ | 44,802 | $ | 16,478 | ||||||||
| All other countries | 1,503 | — | 3,881 | — | ||||||||||||
| Total revenue | 17,731 | 3,101 | 48,683 | 16,478 | ||||||||||||
| Cost of sales | ||||||||||||||||
| United States | 13,539 | 2,718 | 37,108 | 10,985 | ||||||||||||
| All other countries | 836 | — | 2,338 | — | ||||||||||||
| Total cost of sales | 14,375 | 2,718 | 39,446 | 10,985 | ||||||||||||
| Segment operating loss | ||||||||||||||||
| United States | (4,540 | ) | (3,360 | ) | (15,849 | ) | (15,901 | ) | ||||||||
| All other countries | 529 | (3 | ) | 1,225 | (6 | ) | ||||||||||
| Total segment operating loss | (4,011 | ) | (3,363 | ) | (14,624 | ) | (15,907 | ) | ||||||||
| Corporate non-operating expense, net | (268 | ) | (1,483 | ) | (574 | ) | (1,923 | ) | ||||||||
| Loss from continuing operations before income taxes | $ | (4,279 | ) | $ | (4,846 | ) | $ | (15,198 | ) | $ | (17,830 | ) | ||||
| September 30, 2017 |
December 31, 2016 |
|||||||||||||||
| Assets | ||||||||||||||||
| United States | $ | 70,141 | $ | 78,546 | ||||||||||||
| All other countries | 3,247 | 2,754 | ||||||||||||||
| Assets held for disposal | 451 | 1,507 | ||||||||||||||
| Total assets | $ | 73,839 | $ | 82,807 | ||||||||||||
12
Note 6. Fair Value Measurements
Derivative Warrant Liabilities
The following table presents the placement in the fair value hierarchy of derivative warrant liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016:
| Fair value measurement at reporting date using | ||||||||||||||||
| Quoted prices in | ||||||||||||||||
| active markets | Significant other | Significant | ||||||||||||||
| for identical | observable | unobservable | ||||||||||||||
| Balance | assets (Level 1) | inputs (Level 2) | inputs (Level 3) | |||||||||||||
| September 30, 2017: | ||||||||||||||||
| May 2015 Warrants | $ | 52 | $ | — | $ | — | $ | 52 | ||||||||
| December 31, 2016: | ||||||||||||||||
| May 2015 Warrants | $ | 259 | $ | — | $ | — | $ | 259 | ||||||||
The Company measures its derivative warrant liabilities at fair value. The May 2015 Warrants were classified within Level 3 because they were valued using the Black-Scholes-Merton model, which utilizes significant inputs that are unobservable. These derivative warrant liabilities were initially measured at fair value and are marked to market at each balance sheet date.
In addition to the above, the Company’s financial instruments as of September 30, 2017 and December 31, 2016 consisted of cash and cash equivalents, receivables, accounts payable and Debt. The carrying amounts of all the aforementioned financial instruments approximate fair value because of the short-term maturities of these instruments.
The following table summarizes the changes in the Company’s derivative warrant liabilities measured at fair value using significant unobservable inputs (Level 3) during the three- and nine-month periods ended September 30, 2017:
| May 2015 Warrants | ||||
| December 31, 2016 | $ | 259 | ||
| Decrease in fair value of the derivative warrant liabilities | (159 | ) | ||
| June 30, 2017 | 100 | |||
| Decrease in fair value of the derivative warrant liabilities | (48 | ) | ||
| September 30, 2017 | $ | 52 | ||
Valuation processes for Level 3 Fair Value Measurements
Fair value measurement of the derivative warrant liabilities falls within Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.
September 30, 2017:
| Description | Valuation technique | Unobservable inputs | Range | |||||
| May 2015 Warrants | Black-Scholes-Merton | Volatility | 42.49 | % | ||||
| Risk free interest rate | 1.57 | % | ||||||
| Expected term, in years | 2.59 | |||||||
| Dividend yield | 0.00 | % | ||||||
December 31, 2016:
| Description | Valuation technique | Unobservable inputs | Range | |||||
| May 2015 Warrants | Black-Scholes-Merton | Volatility | 45.15 | % | ||||
| Risk-free interest rate | 1.57 | % | ||||||
| Expected term, in years | 3.34 | |||||||
| Dividend yield | 0.00 | % | ||||||
Sensitivity of Level 3 measurements to changes in significant unobservable inputs
The inputs to estimate the fair value of the Company’s derivative warrant liabilities were the current market price of the Company’s common stock, the exercise price of the derivative warrant liabilities, their remaining expected term, the volatility of the Company’s common stock price and the risk-free interest rate over the expected term. Significant changes in any of those inputs in isolation can result in a significant change in the fair value measurement.
13
Generally, an increase in the market price of the Company’s shares of common stock, an increase in the volatility of the Company’s shares of common stock, and an increase in the remaining term of the derivative warrant liabilities would each result in a directionally similar change in the estimated fair value of the Company’s derivative warrant liabilities. Such changes would increase the associated liability while decreases in these assumptions would decrease the associated liability. An increase in the risk-free interest rate or a decrease in the differential between the derivative warrant liabilities’ exercise price and the market price of the Company’s shares of common stock would result in a decrease in the estimated fair value measurement and thus a decrease in the associated liability. The Company has not, and does not plan to, declare dividends on its common stock and, as such, there is no change in the estimated fair value of the derivative warrant liabilities due to the dividend assumption.
Other Fair Value Measurements
The following table presents the placement in the fair value hierarchy of the contingent consideration assumed by the Company following the acquisition of Excalibur, which is measured at fair value on a recurring basis:
| Fair value measurement at reporting date using | ||||||||||||||||
| Quoted prices in | ||||||||||||||||
| active markets | Significant other | Significant | ||||||||||||||
| for identical | observable | unobservable | ||||||||||||||
| Balance | assets (Level 1) | inputs (Level 2) | inputs (Level 3) | |||||||||||||
| September 30, 2017: | ||||||||||||||||
| Contingent consideration | $ | 316 | $ | — | $ | — | $ | 316 | ||||||||
The purchase value of the contingent consideration assumed by the Company following the acquisition of Excalibur was determined using the Monte-Carlo simulation and, as such, was classified as Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.
Note 7. Stock-based Compensation
As of September 30, 2017, 1,552,480 shares of the Company’s common stock were available for future grants under the Company’s 2012 Employee, Director and Consultant Equity Incentive Plan. Total stock-based compensation expense for the nine-month periods ended September 30, 2017 and 2016 was $2,179 and $1,447, respectively. Total stock-based compensation expense for the three-month periods ended September 30, 2017 and 2016 was $706 and $485, respectively.
The following table illustrates the options granted during the nine-month period ended September 30, 2017.
| Title | Grant date | No. of options |
Exercise price |
Fair value at grant date |
Vesting terms | Assumptions used in
Black-Scholes option pricing model | ||||||
| Directors, management, and employees | January 2017 | 1,545,000 | $2.12 – $2.15 | $0.89 – $0.96 | Over 1 year for directors; Over 3 years for management and employees |
Volatility: 44.27% – 44.90% Risk free interest rate: 1.95% – 2.16% Expected term, in years: 5.29 – 5.79 Dividend yield: 0.00% |
14
The following table illustrates the RSUs granted during the nine-month period September 30, 2017.
| Title | Grant date | No. of RSUs | Fair value at grant date | Vesting term | ||||||||
| Management and employees | January 2017 | 400,942 | $ | 2.12 | Over 1 year period, vesting on 1 year anniversary of grant date | |||||||
The activity related to stock options and RSUs during the nine-month period ended September 30, 2017 consisted of the following:
| RSUs | Options | |||||||||||||||||||||||
| No. of RSUs | Weighted average grant date fair value | No. of options | Weighted average exercise price | Exercise price range | Weighted average grant date fair value | |||||||||||||||||||
| Outstanding as of January 1, 2017 | — | — | 3,679,101 | $ | 7.60 | $ | 1.55 – 55.00 | $ | 5.41 | |||||||||||||||
| Granted | 400,942 | $ | 2.12 | 1,545,000 | $ | 2.12 | $ | 2.12 – 2.15 | $ | 0.93 | ||||||||||||||
| Vested/Exercised | — | — | — | — | — | — | ||||||||||||||||||
| Forfeited | (35,377 | ) | $ | 2.12 | (330,834 | ) | $ | 15.57 | $ | 1.55 – 41.00 | $ | 10.61 | ||||||||||||
| Expired | — | — | (16,368 | ) | $ | 43.66 | $ | 9.94 – 55.00 | $ | 22.02 | ||||||||||||||
| Outstanding as of September 30, 2017 | 365,565 | $ | 2.12 | 4,876,899 | $ | 5.21 | $ | 1.55 – 41.00 | $ | 3.59 | ||||||||||||||
| Exercisable as of September 30, 2017 | — | 2,780,024 | $ | 7.77 | $ | 1.55 – 41.00 | ||||||||||||||||||
15
On January 20, 2017, the Company entered into amended employment agreements with its named executive officers. Under the terms of certain of these agreements, certain of these officers are entitled to a percentage of the amount equal to the total amount of cash and the fair market value of all noncash consideration paid or payable to the Company or its stockholders in connection with an initial public offering or a change of control of certain subsidiaries of the Company. The amended employment agreements also allow for the granting of equity awards to certain officers in connection with an initial public offering of certain subsidiaries of the Company.
The Company did not recognize tax benefits related to its stock-based compensation as there is a full valuation allowance recorded.
Note 8. Income Taxes
The Company’s provision for income taxes consists of federal, state, local, and foreign taxes in amounts necessary to align the Company’s year-to-date provision for income taxes with the effective tax rate that the Company expects to achieve for the full year. Each quarter, the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as deemed necessary. The income tax provisions for the nine months ended September 30, 2017 reflect an estimated global annual effective tax rate of approximately -3.0% from continuing operations. Discontinued operations for the nine months ended September 30, 2017 reflect an annual effective tax rate of 0.0%.
As of September 30, 2017, deferred tax assets generated from the Company’s U.S. activities were offset by a valuation allowance because realization depends on generating future taxable income, which, in the Company’s estimation, is not more likely than not to be generated before such net operating loss carryforwards expire. The Company expects its effective tax rate for its current fiscal year to be significantly lower than the statutory rate as a result of a full valuation allowance; therefore, any loss before income taxes does not generate a corresponding income tax benefit.
Income tax expense for the nine months ended September 30, 2017 of approximately $284 was attributable primarily to tax deductions related to goodwill, for which there is no corresponding financial statement amortization expense, partially offset by the reduction in the valuation allowance needed following the acquisition of Excalibur's deferred tax liability. The final annual tax rate cannot be determined until the end of the fiscal year; therefore, the actual tax rate could differ from current estimates. Although the Company has an immaterial amount of uncertain tax positions, the Company does not expect to record any additional material provisions for unrecognized tax benefits with the next year.
Note 9. Related Parties Transactions
On April 22, 2015, XpresSpa entered into a credit agreement and secured promissory note (the “Debt”) with Rockmore Investment Master Fund Ltd. (“Rockmore”) that was amended on August 8, 2016. Rockmore is an investment entity controlled by the Company’s board member, Bruce T. Bernstein. The Debt had an outstanding balance of $6,500 as of both September 30, 2017 and December 31, 2016, which is included in long-term liabilities in the condensed consolidated balance sheets. During the three- and nine-month period ended September 30, 2017, XpresSpa paid $150 and $580 of interest and recorded $183 and $548 of interest expense, respectively. During May 2017, per the original agreement and with Rockmore’s consent, the Company elected to extend the maturity date of the Debt from May 1, 2018 to May 1, 2019. No other material terms of the Debt were modified.
In addition, the Company paid $212 to Mr. Bernstein in March 2017 for the legal costs incurred in conjunction with the acquisition of XpresSpa and certain legal proceedings related to litigation with Amiral Holdings SAS (“Amiral”) prior to the completion of such acquisition, as Mr. Bernstein was indemnified by XpresSpa and was a defendant in the Amiral legal proceedings. These costs are included in accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheet as of December 31, 2016.
16
Note 10. Discontinued Operations and Assets and Liabilities Held for Disposal
During June 2017, the Company concluded that the requirement to report the results of FLI Charge, a wholly-owned subsidiary included in its technology operating segment, as discontinued operations was triggered. As a result, a non-cash impairment loss of $1,092 relating to FLI Charge’s technology assets and goodwill was recorded as of June 30, 2017.
On October 20, 2017 (the “Closing Date”), the Company sold FLI Charge to a group of private investors and FLI Charge management, who will own and operate FLI Charge. The Company will not be providing any continued management or financing support to FLI Charge.
Total consideration for the sale of FLI Charge is $1,250, payable in installments. The consideration is secured by a note and security agreement. Additionally, the Company is entitled to a 5% royalty, in perpetuity, on the gross revenue of FLI Charge and of any affiliate of FLI Charge with regard to conductive wireless charging, power, or accessories. The Company also received a warrant exercisable in FLI Charge or an affiliate of FLI Charge upon an initial public offering or certain defined events in connection with a change of control. The warrant has a five-year life and is based on a valuation of the lesser of $30,000 or the financing valuation of FLI Charge preceding the initial public offering or certain defined events. The Company is currently evaluating the gain on the sale of FLI Charge.
The following table represents the components of operating results from discontinued operations, as presented in the condensed consolidated statements of operations and comprehensive loss:
|
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Revenue | $ | 10 | 4 | 63 | $ | 33 | ||||||||||
| Cost of sales | (15 | ) | (7 | ) | (83 | ) | (9 | ) | ||||||||
| Depreciation, amortization and impairment | (21 | ) | (21 | ) | (1,189 | ) | (63 | ) | ||||||||
| General and administrative | (182 | ) | (391 | ) | (1,112 | ) | (2,154 | ) | ||||||||
| Loss from discontinued operations before income taxes | (208 | ) | (415 | ) | (2,321 | ) | (2,193 | ) | ||||||||
| Income tax expense | — | — | — | — | ||||||||||||
| Net loss from discontinued operations | $ | (208 | ) | $ | (415 | ) | $ | (2,321 | ) | $ | (2,193 | ) | ||||
In addition, the following table presents the carrying amounts of the major classes of assets and liabilities held for sale as of September 30, 2017 and December 31, 2016, as presented in the condensed consolidated balance sheets.
| September 30, 2017 | December 31, 2016 | |||||||
| Accounts receivable, net | $ | 39 | $ | 45 | ||||
| Inventory | 212 | 53 | ||||||
| Other current assets | 9 | 92 | ||||||
| Property and equipment, net | 191 | 183 | ||||||
| Intangible assets, net | — | 377 | ||||||
| Goodwill | — | 757 | ||||||
| Assets held for disposal | $ | 451 | $ | 1,507 | ||||
| Accounts payable, accrued expenses and other current liabilities | $ | 71 | $ | 196 | ||||
| Deferred revenue | 9 | 10 | ||||||
| Liabilities held for disposal | $ | 80 | $ | 206 | ||||
Note 11. Commitments and Contingencies
Litigation and legal proceedings
Significant judgment is required to determine both the likelihood of there being any potential liability and the estimated amount of a loss related to the Company’s legal matters. Based on the Company’s current knowledge, the Company’s management believes that the amount or range of a potential loss from its outstanding legal matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Company evaluated the matters described below, and assessed the probability and likelihood of the occurrence of liability. Based on management’s estimates, the Company recorded $745, which is included in accounts payable, accrued expenses, and other current liabilities in the condensed consolidated balance sheet as of September 30, 2017.
The Company expenses legal fees in the period in which they are incurred.
17
Cordial
Effective October 2014, XpresSpa terminated its former Airport Concession Disadvantaged Business Enterprise (“ACDBE”) partner, Cordial Endeavor Concessions of Atlanta, LLC (“Cordial”), in several store locations at Hartsfield-Jackson Atlanta International Airport.
On January 3, 2017, XpresSpa filed a lawsuit in the Supreme Court of the State of New York, County of New York against Cordial and several related parties. The lawsuit alleges breach of contract, unjust enrichment, breach of fiduciary duty, fraudulent inducement, fraudulent concealment, tortious interference, and breach of good faith and fair dealing related to XpresSpa’s former partnership with Cordial as XpresSpa’s ACDBE partner in several store locations at Hartsfield-Jackson Atlanta International Airport (the “Cordial Litigation”). On March 3, 2017, XpresSpa filed a first amended complaint against Cordial. On April 5, 2017, Cordial filed a motion to dismiss the Cordial Litigation. On September 12, 2017, the Court held a hearing on the motion to dismiss.
On January 4, 2017, XpresSpa filed a lawsuit in the United States District Court for the Southern District of New York against its former attorney, Kevin Ross, and his law firm, alleging malpractice, unjust enrichment, breach of fiduciary duty, fraudulent inducement, fraudulent concealment, tortious interference, and promissory estoppel related to XpresSpa’s former partnership with Cordial, as well as XpresSpa’s engagement of Kevin Ross as its attorney (the “Ross Litigation”). On March 17, 2017, XpresSpa filed a First Amended Complaint against the defendants. On June 2, 2017, the Ross Defendants filed their answer.
Both the Cordial Litigation and Ross Litigation are pending before the respective courts.
In re Chen et al.
On March 16, 2015, four former employees of XpresSpa who worked at locations in John F. Kennedy International Airport and LaGuardia Airport filed a putative class and collective action wage-hour litigation in the United States District Court for the Eastern District of New York, claiming that they and other spa technicians were misclassified, and that overtime was unpaid. On September 23, 2016, the Court conditionally certified the class. The parties held a mediation on February 28, 2017 and reached an agreement on a settlement in principle. On September 6, 2017, the parties entered into a settlement agreement. On September 15, 2017, the parties filed a motion for settlement approval with the Court; this motion is pending. In October 2017, XpresSpa paid the agreed-upon settlement amount to the settlement claims administrator, to be held in escrow pending a fairness hearing and final approval by the Court.
Other
XpresSpa is involved in various other claims and legal actions that arise in the ordinary course of business. The Company does not believe that the ultimate resolution of these actions will have a material adverse effect on XpresSpa’s financial position, results of operations, liquidity, or capital resources. However, a significant increase in the number of these claims, or one or more successful claims under which the Company incurs greater liabilities than the Company currently anticipates, could materially adversely affect the Company’s business, financial condition, results of operations and cash flows.
The Company’s intellectual property operating segment is engaged in litigation, for which no liability is recorded, as the Company does not expect a material negative outcome.
On November 6, 2017, Moreton Binn and Marisol F, LLC, former shareholders of XpresSpa, filed a lawsuit against the Company and its directors alleging that the defendants engaged in securities violations, misrepresentation, and various other allegations regarding the Company’s acquisition of XpresSpa. The Company is currently in the process of evaluating the claims.
18
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
This Quarterly Report on Form 10-Q contains “forward-looking statements” that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The statements contained herein that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipates,” “believes,” “can,” “continues,” “could,” “estimates,” “expects,” “intends,” “may,” “will be,” “plans,” “projects,” “seeks,” “should,” “targets,” “will,” “would,” and similar expressions or variations intended to identify forward-looking statements. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2016 filed on March 30, 2017 (the “2016 Annual Report”) and this Quarterly Report on Form 10-Q and any future reports we file with the Securities and Exchange Commission (“SEC”). The forward-looking statements set forth herein speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements, except as required by law.
All references in this Quarterly Report on Form 10-Q to “we,” “us” and “our” refer to FORM Holdings Corp. (prior to May 5, 2016, known as “Vringo, Inc.”), a Delaware corporation, and its consolidated subsidiaries.
Overview
FORM Holdings Corp. (“FORM” or the “Company”) has three operating segments: wellness, technology and intellectual property.
Our wellness operating segment consists of XpresSpa, which is a leading airport retailer of spa services. XpresSpa is a well-recognized airport spa brand with 51 locations, consisting of 47 domestic and 4 international, as of September 30, 2017. XpresSpa offers travelers premium spa services, including massage, nail and hair as well as spa and travel products. We acquired XpresSpa in the fourth quarter of 2016.
Our technology operating segment consists of Group Mobile as well as an 11% equity interest in InfoMedia Services Limited (“InfoMedia”). Group Mobile offers rugged hardware and software solutions, including laptops, tablets, and mobile printers, as well as installation and deployment services. In the first quarter 2017, we completed the acquisition of Excalibur Integrated Systems, Inc. (“Excalibur”) which is an end-to-end solutions provider of mobile hardware devices, wireless network security, data networking, telephony and mobile application development and software solutions. Following the acquisition, Excalibur was merged with Group Mobile within our technology operating segment. Our equity interest in InfoMedia, which is accounted for under the cost method of investment, increased from 8.25% to 11% in the first quarter of 2017 due to a realignment of ownership interests.
We are currently evaluating strategic alternatives with respect to Group Mobile in an attempt to enhance stockholder value. These strategic alternatives may include a possible sale, merger, spin-off or other separation of Group Mobile or other forms of business combinations or strategic transactions. We are seeking to enter into one or more strategic transactions involving Group Mobile in the first quarter of 2018.
As of September 30, 2017, our FLI Charge business is reflected as discontinued operations in our condensed consolidated statements of operations and comprehensive loss and assets held for disposal and liabilities held for disposal in our condensed consolidated balance sheets. FLI Charge was subsequently sold during October 2017.
Our intellectual property operating segment is engaged in the monetization of patents related to content and ad delivery, remote monitoring and mobile technologies.
On July 26, 2017, we entered into the Underwriting Agreement with Roth Capital Partners, LLC, acting as the representative of the Underwriters, relating to the Offering of 6,900,000 shares of FORM Common Stock including 900,000 shares subject to the Underwriters’ over-allotment option, which was exercised on August 2, 2017 and closed on August 4, 2017. The price to the public in the Offering was $1.10 per share and the Underwriters agreed to purchase the shares of FORM Common Stock from us pursuant to the Underwriting Agreement at a purchase price of $1.023 per share. The net proceeds to us from the Offering were $6,584,000 after deducting underwriting discounts and commissions and other estimated offering expenses.
19
Third Quarter 2017 Highlights
| Three Months Ended September 30, 2017 | ||||||||||||||||||||
| Wellness | Technology | Intellectual Property | Corporate | Total | ||||||||||||||||
| Total revenue | $ | 12,652,000 | $ | 4,879,000 | $ | 200,000 | $ | — | $ | 17,731,000 | ||||||||||
| Cost of sales | ||||||||||||||||||||
| Products | 1,005,000 | 3,902,000 | — | — | 4,907,000 | |||||||||||||||
| Labor | 6,458,000 | — | — | — | 6,458,000 | |||||||||||||||
| Occupancy | 1,950,000 | — | — | — | 1,950,000 | |||||||||||||||
| Other operating costs | 934,000 | — | 126,000 | — | 1,060,000 | |||||||||||||||
| Total cost of sales | 10,347,000 | 3,902,000 | 126,000 | — | 14,375,000 | |||||||||||||||
| Gross profit | 2,305,000 | 977,000 | 74,000 | — | 3,356,000 | |||||||||||||||
| Gross profit as a % of total revenue | 18.2 | % | 20.0 | % | 37.0 | % | — | 18.9 | % | |||||||||||
| Depreciation and amortization | ||||||||||||||||||||
| Depreciation | 1,110,000 | 24,000 | — | 7,000 | 1,141,000 | |||||||||||||||
| Amortization | 597,000 | 150,000 | 6,000 | — | 753,000 | |||||||||||||||
| Total depreciation and amortization | 1,707,000 | 174,000 | 6,000 | 7,000 | 1,894,000 | |||||||||||||||
| General and administrative | ||||||||||||||||||||
| Stock-based compensation | — | — | — | 706,000 | 706,000 | |||||||||||||||
| Other general and administrative | 2,237,000 | 1,293,000 | (149,000 | ) | 1,386,000 | 4,767,000 | ||||||||||||||
| Total general and administrative | 2,237,000 | 1,293,000 | (149,000 | ) | 2,092,000 | 5,473,000 | ||||||||||||||
| Operating income (loss) from continuing operations | $ | (1,639,000 | ) | $ | (490,000 | ) | $ | 217,000 | $ | (2,099,000 | ) | $ | (4,011,000 | ) | ||||||
We use GAAP and non-GAAP measurements to assess the trends in our business. With respect to XpresSpa, we review its Adjusted EBITDA, a non-GAAP measure, which we define as earnings before interest, tax, depreciation and amortization expense, excluding merger and acquisition, integration and one-time costs and stock-based compensation.
Adjusted EBITDA has been presented in this Quarterly Report on Form 10-Q and is a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP. We consider Adjusted EBITDA to be an important indicator for the performance of our business, but not a measure of performance or liquidity calculated in accordance with U.S. GAAP. We have included this non-GAAP financial measure because management utilizes this information for assessing our performance and liquidity, and as an indicator of our ability to make capital expenditures and finance working capital requirements. We believe that Adjusted EBITDA is a measurement that is commonly used by analysts and some investors in evaluating the performance and liquidity of companies such as us. In particular, we believe that it is useful for analysts and investors to understand this indicator because it excludes transactions not related to our core cash operating activities. We believe that excluding these transactions allows investors to meaningfully analyze the performance of our core cash operations. Adjusted EBITDA should not be considered in isolation or as an alternative to cash flow from operating activities or as an alternative to operating income or as an indicator of operating performance or any other measure of performance derived in accordance with GAAP. In evaluating our performance as measured by Adjusted EBITDA, we recognize and consider the limitations of this measurement. Adjusted EBITDA does not reflect our obligations for the payment of income taxes, interest expense, or other obligations such as capital expenditures. Accordingly, Adjusted EBITDA is only one of the measurements that management utilizes.
The following table provides a reconciliation of operating loss from continuing operations for our three operating segments and corporate to Adjusted EBITDA income (loss) for the three months ended September 30, 2017:
| Three Months Ended September 30, 2017 | ||||||||||||||||||||
| Wellness | Technology | Intellectual Property | Corporate | Total | ||||||||||||||||
| Operating income (loss) from continuing operations | $ | (1,639,000 | ) | $ | (490,000 | ) | $ | 217,000 | $ | (2,099,000 | ) | $ | (4,011,000 | ) | ||||||
| Plus: | ||||||||||||||||||||
| Depreciation and amortization | 1,707,000 | 174,000 | 6,000 | 7,000 | 1,894,000 | |||||||||||||||
| Stock-based compensation | — | — | — | 706,000 | 706,000 | |||||||||||||||
| Merger and acquisition, integration and one-time costs | 529,000 | 290,000 | — | — | 819,000 | |||||||||||||||
| Adjusted EBITDA income (loss) | $ | 597,000 | $ | (26,000 | ) | $ | 223,000 | $ | (1,386,000 | ) | $ | (592,000 | ) | |||||||
Merger and acquisition, integration and one-time costs relate to the following:
| • | For our wellness operating segment, one-time costs related to the interruption of business due to hurricanes that affected our locations in Houston, Texas, Miami and Orlando, Florida, and Atlanta, Georgia. These one-time costs of $200,000 directly impacted our cost of sales. Without these one-time costs, our wellness operating segment’s gross profit would have been $2,505,000, or 19.7% of the wellness operating segment’s total revenue. |
| • | For our wellness operating segment, integration costs related to the acquisition amounted to $329,000, which were recorded in general and administrative expense. |
| • | For our technology operating segment, $290,000 of one-time reorganization and personnel re-alignment related costs. |
Our operating segments are defined as components of an enterprise about which separate financial information is available that is regularly evaluated by the enterprise’s chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. We concluded that we conduct our business through three operating segments, which are also our reportable segments: wellness, technology and intellectual property.
Segment operating results reflect income (loss) before corporate and unallocated shared expenses, interest expense, income taxes and noncontrolling interests.
20
Wellness
Our wellness operating segment recognized revenue of $12,652,000 during the third quarter of 2017, which was generated by XpresSpa for services provided and health and beauty products sold. We acquired XpresSpa on December 23, 2016 and are actively integrating its corporate functions and optimizing the operating segment’s performance. During the nine-month period ended September 30, 2017, we opened three new flagship locations, consisting of one location at John F. Kennedy International Airport’s Terminal 4 and two locations at Phoenix Sky Harbor International Airport. We also closed three small temporary kiosks to better align our resources. We also completed a major renovation to another location in John F. Kennedy International Airport’s Terminal 4, which opened in September 2017. A number of our stores will be undergoing maintenance or renovations during the fourth quarter of 2017. Wherever possible, we seek to receive lease extensions or other concessions when we undergo these processes. As of September 30, 2017, we operated a total of 51 XpresSpa locations.
Store-level costs include all costs that are directly attributable to the store operations and include:
| • | payroll and related benefits for our store operations and store-level management; |
| • | rent, percentage rent and other occupancy costs; |
| • | the cost of merchandise as well as its freight, shipping and handling costs; |
| • | service supplies; |
| • | inventory shortage and valuation adjustments, including purchase price allocation increase in fair values which was recorded as part of the acquisition; and |
| • | costs associated with our sourcing operations. |
General and administrative costs include insurance, infrastructure, payroll and benefits, inventory planning, marketing and other costs. Also included in general and administrative costs are expenses related to one-time costs related to the interruption of business due to hurricanes that affected our locations in Houston, Texas, Miami and Orlando, Florida, and Atlanta, Georgia and the integration costs related to the acquisition, which together amounted to $529,000 during the third quarter of 2017.
Depreciation and amortization costs include the depreciation of leasehold improvements and equipment and the amortization of the brand and customer relationship intangible assets, which were recorded at fair value as of the acquisition date.
Technology
Our technology operating segment predominantly includes revenues and cost of sales generated by Group Mobile and Excalibur. During the third quarter of 2017, Group Mobile’s revenue increased 178.6% from $1,751,000 for the three-month period ended September 30, 2016 to $4,879,000 for the three-month period ended September 30, 2017. This was mainly due to the increased sales pipeline throughout 2016 and 2017.
Intellectual Property
The intellectual property operating segment includes revenues from one-time patent licenses as well as expenses incurred in connection with our patent licensing and related internal payroll expenses. In July 2017, the intellectual property operating segment recognized a $148,000 gain on the sale of an asset.
Corporate
Corporate and unallocated shared expenses principally consist of costs for corporate functions, rent for office space, stock-based compensation, executive management and certain unallocated administrative support functions.
Discontinued Operations
During June 2017, we concluded that the requirement to report the results of FLI Charge, a wholly-owned subsidiary included in our technology operating segment, as discontinued operations was triggered. As a result, a non-cash impairment loss of $1,092,000 relating to FLI Charge’s technology assets and goodwill was recorded during the second quarter of 2017.
On October 20, 2017, we sold FLI Charge to a group of private investors and FLI Charge management, who will own and operate FLI Charge. We will not be providing any continued management or financing support to FLI Charge.
Total consideration for the sale of FLI Charge is $1,250,000, payable in installments. The consideration is secured by a note and security agreement. Additionally, we are entitled to a 5% royalty, in perpetuity, on the gross revenue of FLI Charge and of any affiliate of FLI Charge with regard to conductive wireless charging, power, or accessories. We also received a warrant exercisable in FLI Charge or an affiliate of FLI Charge upon an initial public offering or certain defined events in connection with a change of control. The warrant has a five-year life and is based on a valuation of the lesser of $30,000,000 or the financing valuation of FLI Charge preceding the initial public offering or certain defined events. We are currently evaluating the gain on the sale of FLI Charge.
The results of operations for FLI Charge are presented on the condensed consolidated statements of operations and comprehensive loss as consolidated net loss from discontinued operations, which totaled $208,000 and $2,321,000 for the three- and nine-month periods ended September 30, 2017, respectively. In addition, the carrying amounts of assets and liabilities belonging to FLI Charge are presented on the condensed consolidated balance sheets as assets held for disposal and liabilities held for disposal, respectively.
Results of Operations
Three-month period ended September 30, 2017 compared to the three-month period ended September 30, 2016
Revenue
| Three months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Revenue | $ | 17,731,000 | $ | 3,101,000 | $ | 14,630,000 | ||||||
21
During the three-month period ended September 30, 2017, we recorded total revenue of $17,731,000, which represents an increase of $14,630,000 (or 471.8%) compared to the three-month period ended September 30, 2016. Of the increase, XpresSpa generated $12,652,000 of revenue in the third quarter of 2017. We did not recognize any revenue generated by XpresSpa prior to its acquisition on December 23, 2016. Our technology operating segment demonstrated 178.6% growth in quarterly revenues from $1,751,000 for the three-month period ended September 30, 2016 to $4,879,000 for the three-month period ended September 30, 2017.
Our intellectual property segment recognized a one-time lump sum payment of $200,000 in connection with an executed confidential license agreement for the three-month period ended September 30, 2017, a decrease compared to the three-month period ended September 30, 2016, for which our intellectual property operating segment recognized a one-time lump sum payment of $1,350,000 in connection with an executed confidential license agreement.
Cost of sales
| Three months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Cost of sales | $ | 14,375,000 | $ | 2,718,000 | $ | 11,657,000 | ||||||
During the three-month period ended September 30, 2017, we recorded total cost of sales of $14,375,000, which represents an increase of $11,657,000 (or 428.9%) compared to the three-month period ended September 30, 2016. XpresSpa recorded total cost of sales of $10,347,000, which represent direct costs incurred for store operations. As a result, our wellness operating segment’s gross profit for the quarter was 18.2%. Our technology operating segment recorded cost of sales of $3,902,000, which resulted in our technology operating segment generating 20.0% gross margin during the quarter.
During the three-month period ended September 30, 2016, we recorded total cost of sales of $2,718,000. Group Mobile recorded total cost of sales of $1,554,000, which represent direct costs from its product sales. Our intellectual property operating segment’s costs were $1,164,000, which included legal and consulting costs related to the confidential license agreement reached during the quarter and royalty expenses to a previous owner of some of our patents. These intellectual property costs decreased to $126,000 for the three-month period ended September 30, 2017.
We expect our cost of sales will grow over time as our revenues increase. We expect that total cost of sales as a percentage of sales will decline gradually over time as a result of the improvement of store-level performance by our wellness operating segment.
Depreciation, amortization and impairment
| Three months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Depreciation, amortization and impairment | $ | 1,894,000 | $ | 182,000 | $ | 1,712,000 | ||||||
During the three-month period ended September 30, 2017, depreciation and amortization expense totaled $1,894,000, which represents an increase of $1,712,000 (or 940.7%) compared to the amortization expense recorded during the three-month period ended September 30, 2016. There was no impairment expense for the three-month period ended September 30, 2017 and no depreciation or impairment expense recorded for the three-month period ended September 30, 2016.
The overall increase in depreciation, amortization and impairment expense was mainly due to an increase in depreciation expense resulting from leasehold improvements and equipment of $1,110,000 and the amortization of the brand and customer relationship intangible assets of $597,000, which were acquired as part of our acquisition of XpresSpa within our wellness operating segment in December 2016.
We expect depreciation and amortization expense will increase gradually over time for our wellness operating segment as we open more stores and will remain somewhat constant in our technology operating segment.
General and administrative
| Three months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| General and administrative | $ | 5,473,000 | $ | 3,564,000 | $ | 1,909,000 | ||||||
During the three-month period ended September 30, 2017, general and administrative expenses increased by $1,909,000 (or 53.6%) compared to the three-month period ended September 30, 2016. The results of the three-month period ended September 30, 2017 include incremental general and administrative expenses associated with our acquisitions of XpresSpa and Excalibur. The increase for the three-month period ended September 30, 2017 compared to the three-month period ended September 30, 2016 is primarily attributed to $2,237,000 of general and administrative expenses associated with XpresSpa. We did not recognize any general and administrative expenses generated by Excalibur prior to its acquisition on February 2, 2017 or XpresSpa prior to its acquisition on December 23, 2016. Additionally, there was an increase in stock-based compensation expense of $221,000, which was a result of equity awards granted to our directors, management and employees in January 2017.
Non-operating expense, net
| Three months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Non-operating expense, net | $ | 268,000 | $ | 1,483,000 | $ | (1,215,000 | ) | |||||
22
Net non-operating expenses include interest expense, revaluation of derivative warrant liabilities, extinguishment of debt and other non-operating income and expenses.
During the three-month period ended September 30, 2017, we recorded total net non-operating expense in the amount of $268,000 compared to total net non-operating expense in the amount of $1,483,000 recorded during the three-month period ended September 30, 2016.
For the three-month period ended September 30, 2017, we recorded interest expense of $183,000 mainly related to XpresSpa’s Debt as well as other net non-operating expense of $133,000. These expenses were offset by a gain of $48,000 on the revaluation of the derivative warrant liabilities.
For the three-month period ended September 30, 2016, we recorded interest expense of $949,000 for the amortization of the debt discount and debt issuance costs associated with debt that was repaid during July 2016. We also recorded $262,000 of extinguishment of debt when the debt was repaid. These were in addition to other non-operating expenses of $369,000 offset by a gain of $97,000 on the revaluation of the derivative warrant liabilities.
Nine-month period ended September 30, 2017 compared to the nine-month period ended September 30, 2016
Revenue
| Nine months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Revenue | $ | 48,683,000 | $ | 16,478,000 | $ | 32,205,000 | ||||||
During the nine-month period ended September 30, 2017, we recorded total revenue of $48,683,000, which represents an increase of $32,205,000 (or 195.4%) as compared to $16,478,000 recorded in the nine-month period ended September 30, 2016. The results of the nine-month period ended September 30, 2017 include incremental revenues associated with our acquisitions of XpresSpa and Excalibur. We did not recognize any revenue generated by Excalibur prior to its acquisition on February 2, 2017 or XpresSpa prior to its acquisition on December 23, 2016. Our technology operating segment demonstrated 115.8% growth in revenue from $5,478,000 for the nine-month period ended September 30, 2016 to $11,820,000 for the nine-month period ended September 30, 2017.
Cost of sales
| Nine months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Cost of sales | $ | 39,446,000 | $ | 10,985,000 | $ | 28,461,000 | ||||||
During the nine-month period ended September 30, 2017, we recorded total cost of sales of $39,446,000, which represents an increase of $28,461,000 (or 259.1%) compared to the nine-month period ended September 30, 2016. The results of the nine-month period ended September 30, 2017 include incremental cost of sales associated with our acquisitions of XpresSpa and Excalibur. We did not recognize any cost of sales generated by Excalibur prior to its acquisition on February 2, 2017 or XpresSpa prior to its acquisition on December 23, 2016. We expect the cost of sales to increase over time as we incur the full results of operations of XpresSpa and Excalibur.
Depreciation, amortization and impairment
| Nine months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Depreciation, amortization and impairment | $ | 6,849,000 | $ | 13,341,000 | $ | (6,492,000 | ) | |||||
During the nine-month period ended September 30, 2017, depreciation and amortization expense totaled $6,849,000, which represents a decrease of $6,492,000 (or 48.7%) compared to the amortization and impairment expense recorded during the nine-month period ended September 30, 2016. There was no impairment expense for the nine-month period ended September 30, 2017 and no depreciation expense recorded for the nine-month period ended September 30, 2016.
Amortization and impairment expense for the nine months ended September 30, 2016 was significantly higher and was primarily attributed to an $11,937,000 impairment charge to our patents asset group. During the second quarter of 2016, we determined that there were impairment indicators related to certain of our patents. A significant factor considered when making this determination occurred on May 6, 2016, when we changed the name of our company from “Vringo, Inc.” to “FORM Holdings Corp.” and concurrently announced our repositioning as a holding company of small- and middle-market growth companies. We concluded that this factor was deemed a “triggering” event, which required the related patent assets to be tested for impairment. In performing this impairment test, we determined that the patent portfolios, which together represent an asset group, were subject to impairment testing. In the first step of the impairment test, we utilized our projections of future undiscounted cash flows based on our existing plans for the patents. As a result, it was determined that our projections of future undiscounted cash flows were less than the carrying value of the asset group. Accordingly, we performed the second step of the impairment test to measure the potential impairment by calculating the asset group’s fair value as of May 6, 2016. As a result, following amortization for the month of April 2016, we recorded an impairment charge of $11,937,000, or 88.7% of the carrying value of the patents prior to impairment, which resulted in a new carrying value of $1,526,000 on May 6, 2016. Following the impairment, we reevaluated the remaining useful life and concluded that there were no changes in the estimated useful life. There were no impairment indicators related to any of our other amortizable intangible assets during the nine-month period ended September 30, 2017.
23
The overall decrease in depreciation, amortization and impairment expense, when comparing the nine-month period ended September 30, 2017 to the nine-month period ended September 30, 2016, was partially offset by an increase in depreciation expense resulting from leasehold improvements and equipment of $4,567,000 and the amortization of the brand and customer relationship intangible assets of $1,775,000, which were acquired as part of our acquisition of XpresSpa within our wellness operating segment in December 2016. The depreciation expense of $4,567,000 is higher than the typical depreciation expense for the nine-month period due to a formal decision made in April 2017 to perform a complete renovation of our flagship JFK location which resulted in a revision to the useful lives. This resulted in an additional $1,100,000 of depreciation expense related to the JFK location.
We expect depreciation and amortization expense will increase gradually over time as we open more stores in our wellness operating segment and new locations and will remain somewhat constant in our technology operating segment.
General and administrative
| Nine months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| General and administrative | $ | 17,012,000 | $ | 8,059,000 | $ | 8,953,000 | ||||||
During the nine-month period ended September 30, 2017, general and administrative expenses increased by $8,953,000 (or 111.1%) compared to the nine-month period ended September 30, 2016. The results of the nine-month period ended September 30, 2017 include incremental general and administrative expenses associated with our acquisitions of XpresSpa and Excalibur. The increase for the nine-month period ended September 30, 2017 compared to the same period ended September 30, 2016 is primarily attributed to $6,537,000 of general and administrative expenses associated with XpresSpa, of which $1,013,000 related to merger and acquisition, integration, and one-time costs. We did not recognize any general and administrative expenses generated by Excalibur prior to its acquisition on February 2, 2017 or XpresSpa prior to its acquisition on December 23, 2016. Additionally, there was an increase in stock-based compensation expense of $732,000, which was a result of equity awards granted to our directors, management and employees in January 2017.
Non-operating expense, net
| Nine months ended September 30, | ||||||||||||
| 2017 | 2016 | Change | ||||||||||
| Non-operating expense, net | $ | 574,000 | $ | 1,923,000 | $ | (1,349,000 | ) | |||||
Net non-operating expenses include interest expense, revaluation of derivative warrant liabilities, extinguishment of debt and other non-operating income and expenses.
During the nine-month period ended September 30, 2017, we recorded total net non-operating expense in the amount of $574,000 compared to total net non-operating expense in the amount of $1,923,000 recorded during the nine-month period ended September 30, 2016.
For the nine-month period ended September 30, 2017, we recorded interest expense of $550,000 mainly related to XpresSpa’s Debt as well as other net non-operating expense of $231,000. These expenses were reduced by a gain of $207,000 on the revaluation of the derivative warrant liabilities.
For the nine-month period ended September 30, 2016, we recorded interest expense of $1,697,000 for the interest recorded related to the monthly interest payments and the amortization of the debt discount and debt issuance costs as well as accrued interest calculated using the effective interest method associated with debt that was repaid during July 2016. There was also $472,000 of extinguishment of debt recorded when the debt was repaid. These non-operating expenses were offset by a gain of $97,000 on the revaluation of the derivative warrant liabilities and other net non-operating income of $149,000.
24
Liquidity and Capital Resources
Our primary liquidity and capital requirements are for new XpresSpa locations for our wellness operating segment, as well as working capital for our technology operating segment. As of September 30, 2017, we had cash and cash equivalents of $10,072,000 that we expect to utilize, along with cash flows from operations, to provide capital to support the growth of our business, primarily through opening new XpresSpa locations, maintaining our existing XpresSpa locations, purchasing inventory for Group Mobile to support the growth in sales and maintaining corporate functions. In addition, we have approximately $7,342,000 of trade receivables, inventory and other current assets to support our working capital needs.
On July 26, 2017, we entered into the Underwriting Agreement with Roth Capital Partners, LLC, acting as the representative of the Underwriters, relating to the Offering of 6,900,000 shares of FORM Common Stock including 900,000 shares subject to the Underwriters’ over-allotment option, which was exercised on August 2, 2017 and closed on August 4, 2017. The price to the public in the Offering was $1.10 per share and the Underwriters agreed to purchase the shares of FORM Common Stock from us pursuant to the Underwriting Agreement at a purchase price of $1.023 per share. Our net proceeds from the Offering were $6,584,000 after deducting underwriting discounts and commissions and other estimated offering expenses.
Our total cash decreased from $17,910,000 as of December 31, 2016 to $10,072,000 as of September 30, 2017. Approximately $11,057,000 of the cash outflow during the nine-month period ended September 30, 2017 was related either to non-recurring payments, capital expenditures or payments for inventory, the latter of which is reflected as a current asset in the condensed consolidated balance sheets.
Key payments and items from December 31, 2016 to September 30, 2017:
| Cash spent on inventory on-hand | $ | 1,830,000 | ||
| Overdue payables acquired as part of XpresSpa | 1,500,000 | |||
| Capital expenditures for stores and technology | 3,065,000 | |||
| Merger and acquisition and integration-related professional fees | 1,595,000 | |||
| Leases and tax-related matters | 587,000 | |||
| Interest paid on Debt | 580,000 | |||
| Repayment of line of credit upon Excalibur acquisition | 361,000 | |||
| XpresSpa severance | 407,000 | |||
| Cash outflow related to discontinued operations | 1,132,000 | |||
| $ | 11,057,000 |
Based on our current operating plans, we expect to have sufficient funds for at least the next 12 months of operations following the date of these financial statements. In addition, we may choose to raise additional funds in connection with new store openings and potential acquisitions of operating assets, which will be complementary to our wellness operating segment. There can be no assurance, however, that any such opportunities will materialize.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities that would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.
Critical Accounting Estimates
These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC on March 30, 2017, which includes a description of our critical accounting policies that involve subjective and complex judgments that could potentially affect reported results. While there have been no material changes to our critical accounting policies as to the methodologies or assumptions we apply under them, we continue to monitor such methodologies and assumptions.
25
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Not required as we are a smaller reporting company.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
As of September 30, 2017, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
The scope of management's assessment of the effectiveness of internal control over financial reporting includes all of our subsidiaries except Excalibur, which was acquired on February 2, 2017. Our consolidated revenue for the nine-month period ended September 30, 2017 was $48,683,000, of which Excalibur represented $4,195,000, and our total assets as of September 30, 2017 were $73,839,000, of which Excalibur represented $4,772,000.
Changes in Internal Control over Financial Reporting
On February 2, 2017, we acquired Excalibur, which is an end-to-end solutions provider of mobile hardware devices, wireless network security, data networking, telephony and mobile application development and software solutions. Following the acquisition, Excalibur was merged with Group Mobile within our technology operating segment. We are currently in the process of evaluating and integrating Excalibur's historical internal controls over financial reporting into ours.
Other than this change, there were no changes in our internal control over financial reporting during the quarter ended September 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
For information regarding legal proceedings, see Note 11 “Commitments and Contingencies” in our notes to the condensed consolidated financial statements included in “Item 1. Financial Statements.”
Our business, financial condition, results of operations and the trading price of our common stock could be materially adversely affected by any of the following risks as well as the other risks highlighted in our Form 10-K for the year ended December 31, 2016 filed with the SEC on March 30, 2017. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may materially affect our business, financial condition and results of operations.
Risks Related to XpresSpa
Our growth strategy is highly dependent on our ability to successfully identify and open new XpresSpa locations.
Our growth strategy primarily contemplates expansion through procuring new XpresSpa locations and opening new XpresSpa stores and kiosks. Implementing this strategy depends on our ability to successfully identify new store locations. We will also need to assess and mitigate the risk of any new store locations, to open the stores on favorable terms and to successfully integrate their operations with ours. We may not be able to successfully identify opportunities that meet these criteria, or, if we do, we may not be able to successfully negotiate and open new stores on a timely basis. If we are unable to identify and open new XpresSpa locations in accordance with our operating plan, our revenue growth rate and financial performance may fall short of our expectations.
26
Risks Related to Our Common Stock
We may fail to meet publicly announced financial guidance or other expectations about our business, which would cause our stock to decline in value.
From time to time, we provide preliminary financial results or forward looking financial guidance, to our investors. Such statements are based on our current views, expectations and assumptions that may not prove to be accurate and may vary from actual results and involve known and unknown risks and uncertainties that may cause actual results, performance, achievements or share prices to be materially different from any future results, performance, achievements or share prices expressed or implied by such statements. Such risks and uncertainties include the risk factors contained herein and in our Form 10-K for the year ended December 31, 2016. If we fail to meet our projections and/or other financial guidance for any reason, our stock price could decline.
27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
None.
28
|
Exhibit No. |
Description | |
| 31.1* | Certification of Principal Executive Officer pursuant to Exchange Act, Rules 13a - 14(a) and 15d - 14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2* | Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a - 14(a) and 15d - 14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32** | Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 101.INS* | XBRL Instance Document | |
| 101.SCH* | XBRL Taxonomy Extension Schema Document | |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |
| * | Filed herewith. | |
| ** | Furnished herein. |
29
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 9th day of November 2017.
| FORM Holdings Corp. | ||
| By: | /s/ ANASTASIA NYRKOVSKAYA | |
| Anastasia Nyrkovskaya | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) | ||
30
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Andrew D. Perlman, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of FORM Holdings Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s first fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 9, 2017
| /s/ ANDREW D. PERLMAN | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Anastasia Nyrkovskaya, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of FORM Holdings Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s first fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 9, 2017
| /s/ ANASTASIA NYRKOVSKAYA | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) |
Exhibit 32
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PERSUANT SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of FORM Holdings Corp., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the quarter ended September 30, 2017 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 9, 2017
| /s/ ANDREW D. PERLMAN | ||
| Andrew D. Perlman | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |
Date: November 9, 2017
| /s/ ANASTASIA NYRKOVSKAYA | ||
| Anastasia Nyrkovskaya | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) |